NL
HZNP

NWAM LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

NWAM LLC’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,054
Closed -$238K – 579
2023
Q3 		$238K Hold
2,054
– – 0.02% 436
2023
Q2 		$211K Hold
2,054
– – 0.02% 498
2023
Q1 		$224K Sell
2,054
-137
-6% -$15.1K 0.02% 431
2022
Q4 		$249K Buy
+2,191
New +$182K 0.02% 446
2022
Q2 		– Sell
-2,019
Closed -$212K – 572
2022
Q1 		$212K Sell
2,019
-212
-10% -$20.7K 0.02% 500
2021
Q4 		$240K Buy
2,231
+26
+1% +$2.84K 0.02% 454
2021
Q3 		$242K Buy
2,205
+3
+0.1% +$311 0.02% 438
2021
Q2 		$206K Buy
+2,202
New +$203K 0.02% 446

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NWAM LLC's HZNP Position: Q4 2023 in Review

NWAM LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,054 shares — an estimated $238K sold.

NWAM LLC first reported a position in HZNP in Q2 2021 and held it in 8 quarters. The position peaked at $249K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • NWAM LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • NWAM LLC sold 2,054 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $238K.
  • NWAM LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 8 quarters.
  • NWAM LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $249K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on NWAM LLC's 13F filing for Q4 2023, filed 14 Feb 2024.